An antibody testing boom on the horizon? https://www.medicaldevice-network.com/features/covid-19-test-stocks/
An antibody testing boom could be on the horizon
With all this in mind, a vaccine isn’t about to be rolled out tomorrow morning. Safety data still needs ironing out, and the logistics of delivering vaccines to the global population en-masse are rather complex. We may have a viable vaccine soon, but it’s not here yet, and the financial hit to diagnostics companies bolstered by their Covid-19 portfolios is arguably a premature one.
A vaccine could also boost demand for antibody testing, even as it reduces demand for antigen tests. Diagnostics that assess people’s immune response could be used to assess the duration of immunity granted by the vaccine by public health bodies, which could provide a fairly significant lift for developers of such devices.
Also a new post on LinkedIn from MIR, same article